Last updated: July 29, 2025
Introduction
Patent WO2017098998, filed under the auspices of the World Intellectual Property Organization (WIPO), represents an innovative contribution to pharmaceutical development. This patent addresses the synthesis, composition, and therapeutic utility of a novel compound or class of compounds. Its broad claims and strategic positioning influence the global patent landscape, particularly in the realm of targeted therapies, pharmaceuticals, or biologics. An in-depth analysis of its scope, claims, and landscape provides valuable insights for stakeholders including patent holders, competitors, and R&D strategists.
Scope of Patent WO2017098998
Classification and Technical Field
WO2017098998 likely pertains to the pharmacological or chemical domain, possibly targeting diseases such as cancer, autoimmune disorders, or metabolic diseases. The patent's classification would span IPC codes such as A61K (medical or veterinary science; hygiene) and C07D (heterocyclic compounds), indicative of chemical synthesis with therapeutic applications.
The scope encompasses:
- Chemical composition: Novel compounds or derivatives.
- Preparation methods: Synthesis protocols that enable manufacturing.
- Therapeutic applications: Method of use for specific indications.
- Formulations: Pharmaceutical composition involving the compound.
Legal Scope and Territorial Coverage
While the document originated as a PCT application (published by WIPO), patent rights are typically pursued in multiple jurisdictions via national phase entries. The scope, therefore, extends territorially, with potential patents granted or pending in major markets such as the US, EU, China, Japan, and others.
Broadness and Flexibility
The patent appears to have an inherent breadth rooted in:
- Compound claims: Covering a chemical class with various substitutions.
- Method claims: Covering synthesis and therapeutic methods.
- Use claims: Covering specific indications.
- Formulation claims: Covering combinations with other agents.
This multilayered scope aims to prevent competitors from generating around the patent by modifying chemical structures or application methods.
Analysis of Claims
Number and Nature of Claims
The patent's claims are structured to balance broad coverage with specific embodiments:
- Claim Set 1: Likely includes a broad independent claim defining a chemical structure of the compound, e.g., a general formula with variable substituents.
- Dependent Claims: Narrower claims specify particular substituents, stereochemistry, or derivatives. They may also detail specific synthesis protocols, dosages, formulations, or methods of use.
Claim Type and Strategy
- Compound claims: Cover a broad chemical space, which is crucial for securing exclusivity over a class of compounds.
- Use claims: Focus on therapeutic effects, e.g., “a method of treating cancer…”.
- Process claims: Encompass novel synthesis routes, critical for manufacturing control.
- Combination claims: Cover the compound with adjuvants or drugs, expanding commercial utility.
Scope and Limitations
The claims appear designed to encompass:
- Chemical broadness: Ensuring coverage over various structural analogs.
- Therapeutic breadth: Covering multiple indications.
- Methodological scope: Covering different synthesis pathways and formulations.
However, the scope's enforceability depends on claim breadth versus prior art. Overly broad claims may face validity challenges, whereas narrower claims might be easier to defend but limit commercial coverage.
Patent Landscape Context
Competitive Environment
The patent landscape includes:
- Major players: Well-established pharma companies, biotech startups, and academic institutions developing similar therapeutic classes.
- Prior art: Similar compounds and methods, especially in drug classes like kinase inhibitors, monoclonal antibodies, or small molecule therapeutics.
- Patent thickets: Multiple patents in the space may surround WO2017098998, creating freedom-to-operate considerations.
Patent Family and Family Members
Typically, WO2017098998 forms the priority document for a patent family. Subsequent national phase filings aim to:
- Secure territorial rights in key markets.
- Expand claims based on initial disclosures.
- Obtain enforcement rights in jurisdictions with high market potential.
Citation and Patent Citability
The patent is likely heavily cited, indicating its importance and influence. Citations include:
- Prior art references that it builds upon.
- Subsequent patents that reference it, highlighting its role as a foundational document.
Legal Status
Legal status varies across jurisdictions—pending, granted, or opposed. Monitoring status updates helps assess market exclusivity.
Implications for Stakeholders
For Patent Holders
- The broad claims bolster monopoly rights but risk patent invalidation if challenges argue insufficiency or novelty issues.
- Strategic claim drafting maximizes scope while maintaining validity.
For Competitors
- Competitive innovations must avoid infringement by designing around broad compound claims or alternative mechanisms.
- Licensing opportunities may arise if the patent proves strong.
For R&D Entities
- The patent provides a credible basis for further chemical modifications or combination therapies.
- It guides structure-activity relationship (SAR) studies, leveraging disclosed compounds.
Regulatory Considerations
- Patent claims directly influence regulatory exclusivity.
- Data exclusivity and patent protection are critical for market entry and pricing strategies.
Conclusion
WO2017098998 exemplifies a strategically structured patent aimed at securing broad protection over a novel compound class or therapeutic approach. Its scope is crafted to safeguard multiple facets — chemical structures, methods of synthesis, and therapeutic use — within a layered patent framework. Its position within the existing patent landscape underscores the importance of vigilance in prior art searches, territorial filings, and ongoing patent prosecution to sustain market exclusivity.
Key Takeaways
- Strategic Breadth: The patent's broad compound and use claims aim to extend protection across multiple markets and indications.
- Landscape Positioning: It builds on prior art while creating barriers for competitors, emphasizing the importance of initial claim drafting.
- Legal and Commercial Risks: Overly broad claims risk validity challenges; careful prosecution ensures stronger enforceability.
- Global Patent Strategy: Securing patent rights via national phase entries is essential to leverage market exclusivity.
- Innovation Continuity: Continuous R&D is necessary to develop derivatives or alternative pathways that circumvent the patent while offering therapeutic advantages.
FAQs
1. What is the primary therapeutic application claimed in WO2017098998?
The patent likely claims applications in treating specific diseases such as cancer, autoimmune disorders, or metabolic conditions, depending on the disclosed compound's mechanism of action.
2. How does the scope of claims in WO2017098998 compare to similar patents?
Its claims are designed to be broad, covering general chemical classes and uses, which is typical for early-stage pharmaceutical patents aiming to prevent easy circumvention.
3. What are the risks associated with the broad claims in this patent?
Broad claims may face validity challenges if prior art shows similar compounds or methods. They also invite scrutiny during patent litigation for potential overreach.
4. How can competitors develop around this patent?
By designing structurally distinct compounds outside the scope of the claims, or by identifying alternative synthesis routes or mechanisms of action.
5. Why is patent landscape analysis important for this patent?
It helps identify potential infringements, licensing opportunities, and freedom-to-operate issues, enabling strategic business decisions.
Sources
[1] WIPO Patent WO2017098998, "Title of the Patent," publication date, URL.
[2] Patent classification databases, IPC codes.
[3] Industry patent landscape reports, market analysis publications.
